Jump Financial’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.93M | Sell |
5,574
-38,854
| -87% | -$20.4M | 0.03% | 580 |
|
|
2025
Q1 | $28.2M | Buy |
44,428
+25,634
| +136% | +$16.3M | 0.39% | 52 |
|
|
2024
Q4 | $13.4M | Buy |
18,794
+17,586
| +1,456% | +$12.5M | 0.28% | 76 |
|
|
2024
Q3 | $1.27M | Sell |
1,208
-4,882
| -80% | -$5.13M | 0.03% | 690 |
|
|
2024
Q2 | $6.4M | Buy |
6,090
+1,604
| +36% | +$1.69M | 0.13% | 170 |
|
|
2024
Q1 | $4.32M | Sell |
4,486
-3,746
| -46% | -$3.61M | 0.12% | 162 |
|
|
2023
Q4 | $7.23M | Buy |
8,232
+5,728
| +229% | +$5.03M | 0.23% | 61 |
|
|
2023
Q3 | $2.06M | Buy |
2,504
+1,259
| +101% | +$1.04M | 0.08% | 353 |
|
|
2023
Q2 | $895K | Buy |
+1,245
| New | +$895K | 0.03% | 734 |
|
|
2022
Q4 | – | Sell |
-944
| Closed | -$650K | – | 1958 |
|
|
2022
Q3 | $650K | Buy |
+944
| New | +$650K | 0.03% | 784 |
|
|
2022
Q2 | – | Sell |
-613
| Closed | -$428K | – | 1958 |
|
|
2022
Q1 | $428K | Sell |
613
-606
| -50% | -$423K | 0.02% | 885 |
|
|
2021
Q4 | $769K | Buy |
+1,219
| New | +$769K | 0.05% | 482 |
|
|
2021
Q3 | – | Sell |
-3,278
| Closed | -$1.83M | – | 1436 |
|
|
2021
Q2 | $1.83M | Buy |
3,278
+2,515
| +330% | +$1.4M | 0.18% | 126 |
|
|
2021
Q1 | $361K | Buy |
+763
| New | +$361K | 0.03% | 532 |
|